Acme-Hardesty, a division of Jacob Stern & Sons, Inc., has formed a new life sciences strategic business unit. The new unit of the specialty ingredients company will focus on new and expanding market segments including nutritional supplements, foods and beverages, animal feed and supplements, and pharmaceutical ingredients.
 
“We have found significant success since we have developed a focused market segment strategy, such as our personal care business unit that was launched in January 2018. With our new life sciences business unit, we will leverage our organizational systems, technology platforms, and supply chains enabling us to deliver even greater value to our customers within this market segment,” said Jeff Kenton, president, Acme-Hardesty.
 
Brian McGrath, who joined the company in October 2021, will lead the business unit as vice president of life sciences. McGrath has 30 years of experience in the specialty chemicals space and has held numerous global leadership positions in business, sales, and supply chain management, including the pharmaceuticals, personal care, and nutrition segments.
 
“We will initially focus our sales efforts on our current product offerings including materials such as MCT (Medium Chain Triglycerides), glycerine, proteins, botanicals, prebiotics and natural sweeteners while we expand into other product platforms through new product introductions, principal partnerships and business development opportunities,” McGrath said.  “We will continue to grow our life sciences portfolio as an innovative supplier of sustainable, renewable and bio-based solutions.”

“This is an important chapter for Acme-Hardesty as we look forward to expanding our reach and capabilities in the Life Sciences segment,” Kenton said.